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BAF180, a subunit of the PBAF chromatin remodel-
ing complex, is frequently mutated in cancer.
Although PBAF regulates transcription, it remains
unclear whether this is what drives tumorigenesis in
cells lacking BAF180. Based on data from yeast,
we hypothesized that BAF180 may prevent tumori-
genesis by promoting cohesion. Here, we show
BAF180 is required for centromeric cohesion in
mouse and human cells. Mutations identified in
tumor samples are unable to support this activity,
and also compromise cohesion-dependent func-
tions in yeast. We provide evidence of genome insta-
bility in line with loss of cohesion, and importantly,
we find dynamic chromosome instability following
DNA damage in cells lacking BAF180. These data
demonstrate a function for BAF180 in promoting
genome stability that is distinct from its well-
characterized role in transcriptional regulation,
uncovering a potent mechanism for its tumor-
suppressor activity.INTRODUCTION
PBAF is a SWI/SNF chromatin remodeling complex found in
mammalian cells. BAF180 is one of three subunits that distin-
guish PBAF (or SWI/SNF-B) from the other SWI/SNF complex,
termed BAF (or SWI/SNF-A). Recent exome sequencing studies
led to the unexpected finding that SWI/SNF subunits are
mutated at a high frequency in many different cancer types,
and in particular, mutations in PBRM1, which encodes
BAF180, were frequently identified, including in over 40% of
renal cell carcinoma samples (Shain and Pollack, 2013; Varela
et al., 2011; Xia et al., 2008), indicating that BAF180 plays a
critical role in preventing tumorigenesis. Even though BAF180
was identified as a regulator of p53-dependent transcriptional
activity (Burrows et al., 2010; Xia et al., 2008), it is unclear
whether this is the mechanism by which it functions as a
tumor-suppressor gene.
BAF180 is a large protein with multiple domains, including six
bromodomains (BDs) and two bromo-adjacent homology (BAH)
domains. In yeast, these domains are encoded by three sepa-rate subunits, Rsc1, Rsc2, and Rsc4, which are part of the
RSC chromatin remodeling complex. In addition to regulating
gene transcription, RSC is important for sister chromatid cohe-
sion (Baetz et al., 2004; Huang et al., 2004). Notably, recent
reports demonstrated that defective cohesion results in chro-
mosomal instability (CIN) and aneuploidy, and leads to tumori-
genesis in mammalian cells (Carretero et al., 2013; Guo et al.,
2013; Remeseiro et al., 2012; Solomon et al., 2011, 2013). More-
over, aneuploidy itself can drive further genome instability and
can also, in certain contexts, contribute to tumorigenesis (for
review, see Holland and Cleveland, 2012). These observations
raise the possibility that a major mechanism by which BAF180
functions as a tumor suppressor is by promoting sister chro-
matid cohesion.RESULTS
BAF180 Contributes to Sister Chromatid Cohesion
Specifically at Centromeres in Mammalian Cells
To test whether BAF180 is important for sister chromatid cohe-
sion, we first prepared chromosome spreads from wild-type
(WT) or BAF180 knockout mouse embryonic stem cells (mESCs)
(Wang et al., 2004). When we scored for cohesion at the centro-
mere, we found that the BAF180/ cells showed a significant in-
crease in the proportion of cells that displayed aberrant cohesion
compared with the WT control cells (Figure 1A).
In higher eukaryotes, the cohesin complex can contain either
SA1 (STAG1) or SA2 (STAG2), and recently it was found that
SA1 is required for cohesion between sister telomeres, whereas
SA2 is required for centromeric cohesion (Canudas and Smith,
2009; Remeseiro et al., 2012). We therefore scored cohesion at
the chromosome arms to determine whether there was also a
defect, and found no statistically significant difference between
the BAF180+/+ and BAF180/ mESCs (Figure 1B), suggesting
that BAF180 specifically promotes cohesion at the centromeres.
To further examine the cohesion defect, we depleted BAF180
using small interfering RNA (siRNA) in human fibroblast cells
(1BR hTERT; Figure 1C) and performed fluorescence in situ
hybridization (FISH; Figure S1). We first measured the distance
between sister chromatids in mitotic cells using a probe specific
to centromere 10. Compared with cells transfected with a non-
targeting control construct, we found a shift in the distribution
of distances between sister chromatids at the centromere (Fig-
ures 1D, top panel, and S1), consistent with the analysis of cohe-
sion in mESCs.Cell Reports 6, 973–981, March 27, 2014 ª2014 The Authors 973
EA
B
C
D
F
Figure 1. BAF180 Promotes Centromeric Sister Chromatid Cohesion
(A and B) Mitotic spreads prepared from WT (+/+) and BAF180 knockout (/) mESCs were analyzed for sister chromatid cohesion at either centromeres (A) or
arms (B). Representative images fromWT and BAF180/mESCs are shown in the top panels. Cells were analyzed according to whether cohesion was defective
at centromeres (open arrows) or arms (open and closed arrows), and cells were scored as ‘‘normal’’ when two or fewer chromosomes showed defects, or
‘‘defective’’ when three or more chromosomes showed defects; 200 cells were scored per genotype.
(C) Analysis of BAF180 depletion efficiency in 1BR-hTERT cells by western blotting. Anti-tubulin was used as a loading control.
(D) FISH analysis of siControl and siBAF180 1BR-hTERT cells using probes directed against the centromere (top, p < 0.001), telomere (middle, p = 0.877), or
chromosome arm (lower panel, p = 0.586). The distances between signals were measured from two independent experiments and the distribution was plotted as
a histogram.
(E) Analysis of BAF180 protein levels in U2OS shBAF180 and shControl stable cells by western blotting. Anti-tubulin was used as a loading control.
(F) FISH analysis of shControl and shBAF180 U20S cells using a probe directed against the centromere (p < 0.001). The distances between signals were
measured from two independent experiments and the distribution was plotted as a histogram.
See also Figure S1.
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Figure 2. BAF180 Is Not Required for
Transcription of Cohesin Genes and Has
Tissue-Specific Roles in Regulating p53-
Dependent p21 Transcription
(A) Western blot analysis of cohesin subunits in
WCE prepared from WT (+/+) and BAF180
knockout (/) mESCs.
(B) Transcription of cohesin subunits in BAF180-
depleted 1BR-hTert cells. Transcript levels from
three independent experiments were analyzed by
qPCR and normalized to a-tubulin transcript. Data
for BAF180-depleted cells are shown relative to
siControl cells.
(C) Transcription of cohesin subunits in
shBAF180 U2OS cells. Transcript levels from three
independent experiments were analyzed by qPCR
and normalized to a-tubulin. Data for shBAF180
cells are shown relative to shControl cells.
(D) Transcription of p21 in BAF180-depleted 1BR-
hTert and U2OS cells. Transcript levels from three
independent experiments were analyzed by qPCR
and normalized to b-actin. Data for BAF180-
depleted cells are shown relative to control cells.
See also Figure S2.The data we obtained from mouse cells indicated that the
defect in cohesion is specific to the centromere; therefore, we
tested whether BAF180 is also important for mediating cohe-
sion between telomeres. Using a probe against the subtelo-
meric region of chromosome 16, we measured the distribution
of distances between sister chromatids in siBAF180 and
siControl cells as above. In contrast to our results with the
centromeric probe, we found no significant difference in the
BAF180-depleted cells compared with the control cells (Figures
1D, middle panel, and S1). Finally, we used a probe against the
chromosome arm (20p12), and found no substantial difference
between siBAF180 and control cells (Figures 1D, bottom panel,
and S1). These data are similar to results obtained with SA2-
depleted cells (Canudas and Smith, 2009), so we performed
knockdown of SA2 and repeated the analysis of centromeres
by FISH in order to compare the defect with that of BAF180.
We found that the shift in distribution of distances between cen-
tromeres was slightly greater than that of BAF180 (Figure S1),
suggesting that loss of BAF180 may not be as deleterious as
loss of SA2.
To consolidate these data, and for use in future experiments,
we also created a BAF180 small hairpin RNA (shRNA) stable
cell line (and shControl cell line) in U2OS cells (Figure 1E). We
analyzed these cells by FISH as described above using the
centromere-specific probe, and found that, consistent with the
data from mESCs and human fibroblast cells, U2OS cells
depleted of BAF180 have a defect in cohesion at the centromere
(Figure 1F). Together, these data suggest that BAF180 plays a
conserved role in mediating centromeric sister chromatid cohe-
sion in mammalian cells.
BAF180 Is Not Required for Transcription of Cohesin
Genes and Has Tissue-Specific Roles in Regulating
p53-Dependent p21 Transcription
One possible mechanism by which BAF180 mediates sister
chromatid cohesion in cells is transcriptional regulation of cohe-sin genes. In argument against this, a microarray analysis of
BAF180-depleted renal cell carcinomas did not show significant
misregulation of cohesin genes (Varela et al., 2011). Moreover,
we saw no gross differences in the protein levels of core cohesin
subunits when whole-cell extracts from BAF180+/+ and
BAF180/ cells were analyzed by western blotting (Figure 2A).
Nevertheless, to look at this directly in the human cell lines
used in these assays, we examined the mRNA levels of the
core cohesin genes SMC1A, SMC3, SA1 (STAG1), SA2
(STAG2), and RAD21 in siBAF180-treated 1BR hTERT cells
and the stable shBAF180 U2OS cells, and compared them
with controls using quantitative RT-PCR (qRT-PCR). BAF180
depletion did not result in significantly decreased levels of any
of these transcripts (Figures 2B and 2C). In fact, in the
shBAF180 U2OS cells, the RAD21 transcript, and to a lesser
extent the SMC3 and SA1 transcripts, appeared to be upregu-
lated. Together, these data suggest that the defect in cohesion
is unlikely to be due to indirect transcriptional effects.
BAF180 has been implicated in regulating transcription of the
p53-dependent p21 gene (Burrows et al., 2010; Xia et al., 2008),
and this is certainly a mechanism by which loss of BAF180 may
promote tumorigenesis. We set out to investigate the transcrip-
tional status of p21 in our BAF180-depleted cell lines and found
that, consistent with previous reports, the basal levels of p21
transcription were defective in a human fibroblast cell line
(Figure 2D). Moreover, we examined induced p21 transcription
by treating cells with the MDM2 inhibitor nutlin, and found that
these transcripts were also downregulated when BAF180 was
depleted in the 1BR hTERT cells (Figure S2).
In contrast, however, both basal and induced p21 transcripts
were upregulated in the U2OS shBAF180 cells relative to the
shControl cells (Figures 2D and S2), suggesting that p53-depen-
dent transcriptional activation of p21 is BAF180 independent in
these cells. This finding fortuitously allowed us to examine the
effects of BAF180-dependent effects on cohesion in a cell line
where p21 transcription is not reduced.Cell Reports 6, 973–981, March 27, 2014 ª2014 The Authors 975
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Cancer-Associated Mutations of BAF180 Impair
Cohesion in Mammalian Cells and Cohesin-Dependent
Functions in Budding Yeast
A number of missense mutations were identified in the gene
encoding BAF180 (PBRM1) in cancer cells (Varela et al., 2011),
some of which are predicted to have relatively little effect on
protein folding and stability (Brownlee et al., 2012). We consid-
ered the possibility that these mutations might provide some
insight into the mechanism(s) by which BAF180 suppresses
tumorigenesis. We began by looking at the effects of these
cancer mutations in the yeast homolog of BAF180.
We selected three mutations of BAF180 identified in cancer
cells: T232P, M523I, and H1204P. The first two reside in BD2
and BD4 of BAF180, and the last mutation is found within the
second BAH domain of BAF180. When aligned with Rsc1 and
Rsc2, all three residues are conserved within Rsc2 (Figures 3A,
S3A, and S3B; corresponding to T67 in BD1, M280 in BD2,
and H458P in the BAH domain, respectively). Although two of
the residues are also conserved within Rsc1 (Figures S3A and
S3B), Rsc2 has a greater effect on DNA damage responses
and cohesion (Baetz et al., 2004; Chambers et al., 2012), so
we introduced the mutations into Rsc2.
We first transformed WT and mutant Rsc2 expression con-
structs into rsc2 null yeast and then performed western blot
analyses of whole-cell extracts to determine whether they had
any effect on protein stability. We detected a very low level of
Rsc2-H458Pmutant protein compared with theWT control, sug-
gesting that this mutation severely impairs protein stability. The
Rsc2-T67P mutant protein was detected at intermediate levels,
consistent with a slight destabilizing effect, and the Rsc2-
M280I was similar to WT (Figure 3B).
Cells lacking RSC2 have a growth defect and are temperature
sensitive. They are also hypersensitive to DMSO, which likely
reflects transcriptional misregulation of genes involved in cell
wall biosynthesis (Angus-Hill et al., 2001). We found the Rsc2-
H458P mutant strain showed phenotypes similar to those of the
null strain (Figures3CandS3), consistentwith thegreatly reduced
protein levels. In contrast, both of the other mutant proteins were
able to rescue the temperature-sensitivity (ts) and DMSO-hyper-
sensitivity phenotypes of the rsc2 null strain to apparently WT
levels (Figures 3C and S3), as well as to restore the WT levels ofFigure 3. Mutations Identified in BAF180 from Cancer Samples Result
(A) Illustration of domain organization and relative position of cancer-associa
sequentially.
(B) Analysis of WT and mutant Rsc2 expression levels in total protein preparatio
(C) Hypersensitivity to DMSO as a readout of Rsc2-dependent transcriptional ac
onto media with or without 2% DMSO.
(D) Frequency of unequal rDNA crossover events in yeast strains containing the
(E) Expression of GFP-tagged BAF180 constructs in siBAF180 U20S. Cells were tr
BAF180 expression in the red channel.
(F) Analysis of BAF180 depletion efficiency in U2OS cells by western blotting. An
(G) FISH analysis of G2 phase U2OS cells transfected with the indicated BAF18
between signals were measured and the distribution was plotted as a histogram
(H) The data in (G) are presented as a cumulative plot to further illustrate the defe
analysis of the data presented in (G) and (H) showed that rescue of the cohesion de
(p < 0.001). In contrast, centromeric cohesion in cells expressing the cancer muta
empty vector (siBAF180 + GFP; p = 0.06 for T232P and p = 0.37 for M538I), b
(p < 0.001 for both mutants compared with WT).
See also Figures S3 and S4.the HXT7 transcript, which is Rsc2 dependent (Figure S3). These
results indicate that the Rsc2-T67P and Rsc2-M280I mutant
proteins are still at least partly functional in vivo. In contrast, we
found that all of thecancer-mutant-bearing strains showedstatis-
tically significant differences in survival relative to WT following
DNA damage, and none of the cancer-mutant constructs were
able to fully complement the growth defect (Figure S3).
The yeast phenotypes described above could potentially
reflect a loss of cohesion-dependent activities in the cancer-
mutant-containing strains. We therefore tested the mutant
Rsc2 proteins using a recombination assay in which a reporter
construct was integrated into the rDNA repeats. Strains with
defective cohesion showed elevated rates of marker loss
compared with WT, indicative of increased unequal sister chro-
matid exchange events (Huang and Moazed, 2003). As ex-
pected, the rsc2 null cells showed a 3-fold increase in marker
loss compared with the WT control (Figure 3D). Notably, we
found that none of the cancer mutations were able to fully com-
plement this activity (Figure 3D). These data are consistent with
the idea that some cancer-associatedmutations do not compro-
mise all functions of Rsc2, but do compromise the cohesion-
related functions of RSC2 and result in genome instability.
We next created siRNA-resistant GFP-tagged WT and mutant
expression constructs of BAF180. We focused on the two
mutants that were expressed at reasonable levels in yeast:
Rsc2-T67P and M280I. These correspond to BAF180 T232 and
M538 in our construct (isoform 8; Figure S3). We then trans-
fected these constructs into BAF180-depleted cells alongside
WT and empty vector, synchronized them in G2, and analyzed
them by immunofluorescence (IF)-FISH to examine the distance
between sister chromatids in the transfected cells (Figures 3E,
3F, and S4). We found that expression of the mutants was com-
parable to that of the WT construct (Figures 3E and S4), but
although the WT construct was able to restore cohesion, neither
of the cancer-associated mutant constructs could (Figures 3G
and 3H), suggesting that tumor cells bearing these mutations
have compromised centromeric cohesion.
Loss of BAF180 Leads to Dynamic CIN
Defective cohesion leads to both structural and numerical CIN,
due in part to problems with chromosome segregation leadingin Impaired Cohesin-Dependent Functions in Yeast and Mammals
ted mutations in Rsc2 and BAF180. BDs and BAH domains are numbered
ns by western blotting. Loading control: anti-H2A.
tivity was analyzed by plating serial dilutions of the indicated mid-log cultures
indicated Rsc2 expression construct.
eated as in (G) and Figure S4, for IF-FISH. IF using anti-GFP showsGFP or GFP-
ti-tubulin was used as a loading control.
0 expression construct using a probe against centromere 10. The distances
.
ct in cohesion in cells transfected with cancer-associated mutants. Statistical
fect by reintroduction ofWTBAF180 (siBAF180 +GFP-BAF180) was significant
nts was not significantly different from that in BAF180-depleted cells containing
ut was significantly different from that in cells with WT BAF180 reintroduced
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Figure 4. Cells Lacking BAF180 Are Aneuploid
and Show Evidence of CIN
(A) Distribution curves showing chromosome
numbers from WT (+/+) and BAF180 knockout (/)
mESCs. Chromosomes were counted in 100 cells for
each cell line using DAPI-stained metaphase
spreads.
(B) Quantification of micronuclei present in WT (+/+)
or BAF180 knockout (/) mESCs (top panel), con-
trol and BAF180-depleted 1BR-hTERT cells (middle
panel), and shControl and shBAF180 U2OS cells
(bottom panel). A minimum of 900 cells were scored
for each cell line, and siRNA-depleted cells from
three independent experiments were analyzed.
(C) Incidence of abnormal events during anaphase
were quantified in WT (+/+; n = 183) and BAF180
knockout (/; n = 207) mESCs.to aneuploidy, and defective recombination-based repair lead-
ing to structural chromosome aberrations (Xu et al., 2011). Cells
lacking SA2, which have centromeric cohesion defects similar to
BAF180-dependent effects, are aneuploid and show evidence of
both structural and numerical CIN (Solomon et al., 2011). How-
ever, the effect of BAF180 depletion on sister chromatid cohe-
sion is not as pronounced as that reported for SA2-depleted cells
(Figure S2; Canudas and Smith, 2009), raising the possibility that
this defect is not sufficient to disrupt chromosomal stability and
therefore may not impact tumorigenesis. We therefore investi-
gated whether loss of BAF180 leads to CIN.
We first determined whether BAF180 influences aneuploidy by
analyzing chromosome spreads prepared from BAF180/
mESCs, and found that they had an increased average number
of chromosomes per cell when compared with WT (Figure 4A).
Next, we investigated other readouts of CIN. Micronuclei can
arise as a consequence of chromosome missegregation and
are commonly seen in cells with defective cohesion (Barber
et al., 2008; Musio et al., 2003). We observed an increase in
the number of micronuclei present in the BAF180/ mESCs
compared with WT (Figure 4B, top panel). A similar increase
was apparent when we examined the human cell lines depleted
of BAF180 (siBAF180 1BR hTERT cells and shBAF180 U2OS)
when compared with their controls (Figure 4B, middle and lower
panels). Notably, the result obtained in the siBAF180-treated
cells suggests that the effect of BAF180 loss on genome stability
is rapid and does not require extensive cell passaging. Further,
imaging of BAF180/ mESCs showed the presence of in-
creased numbers of lagging chromosomes and anaphase
bridges compared with WT control cells (Figure 4C).
In addition to promoting faithful chromosome segregation,
cohesion is important for mediating recombination in response
to DNA damage, and loss of cohesion leads to structural CIN978 Cell Reports 6, 973–981, March 27, 2014 ª2014 The Authors(Xu et al., 2011). Consequently, mamma-
lian cells with defects in cohesion are
hypersensitive to a number of DNA-
damaging agents, including the crosslink-
ing agent mitomycin C (MMC) (van derLelij et al., 2009; Vrouwe et al., 2007). We therefore tested
whether loss of BAF180 would sensitize cells to MMC. We found
that both BAF180/mESCs and BAF180-depleted 1BR-hTERT
human cells weremore sensitive toMMC than the respectiveWT
cells (Figure 5A). These data suggest that loss of cohesion in the
absence of BAF180 leads to a deficiency in recombination-
based repair of DNA damage, leading to decreased viability after
MMC exposure.
This defect would be expected to further exacerbate CIN in the
absence of BAF180 under these conditions. Consistent with this
idea, we found that the BAF180/ mESCs had a clear increase
in structural aberrations and greater incidence of micronuclei
than the WT controls following exposure to MMC (Figures 5B
and 5C; Table 1). Strikingly, we also found that MMC treatment
led to a profound effect on aneuploidy in the BAF180/ cells
(Figure 5D), providing direct evidence of dynamic CIN in these
cells. We also found that the shBAF180 U2OS cells, where p21
transcripts are not decreased relative to the shControl cells,
also showed evidence of MMC-induced genome instability (Fig-
ure S5). Collectively, these data demonstrate that BAF180 plays
a key role in preventing CIN.
DISCUSSION
We found that BAF180 is important for the establishment or
maintenance of cohesion on chromatin at centromeres. Interest-
ingly, BAF180 is enriched at kinetochores of chromosomes dur-
ing mitosis (Xue et al., 2000), and there is evidence from budding
yeast that kinetochores promote cohesin loading by Scc2-Scc4
(Natsume et al., 2013), raising the possibility that PBAF works
with kinetochores in some way to promote this function.
We found that cancer-associated mutations in BAF180 are
compromised for cohesion and cohesion-dependent functions
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C
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Figure 5. Loss of BAF180 Leads to Hypersensitivity to DNA Damage, Increased Frequency of Chromosome Aberrations, and Dynamic CIN
(A) Viability curves of WT (+/+) or BAF180 knockout (/) mESCs (left panel), and control and BAF180-depleted 1BR-hTERT cells (right panel) following exposure
to MMC.
(B) The presence of chromosomal aberrations in metaphase spreads prepared fromWT (+/+) or BAF180 knockout (/) mESCs following exposure to MMCwas
analyzed and presented as frequency per 100 chromosomes. Images representative of each category are shown in the top panels.
(C) Quantification of micronuclei present in WT (+/+) or BAF180 knockout (/) mESCs following exposure to MMC.
(D) Distribution curves showing chromosome numbers from WT (+/+) and BAF180 knockout (/) mESCs following exposure to MMC.
See also Figure S5.in both yeast and mammalian cells, demonstrating profound
conservation of function. These findings, together with the CIN
that we find in the absence of BAF180, support the notion that
the ability of BAF180 to promote cohesion is important for pre-
venting tumorigenesis. Notably, these data are not incompatible
with the idea that BAF180 also prevents tumorigenesis via its role
in regulating transcription; rather, they uncover an additional
mechanism. In fact, the ability of BAF180 (and PBAF) to function
in multiple pathways to prevent tumorigenesis may make it
particularly critical as a tumor-suppressor gene, andmay explain
the frequency with which subunits of the complex are found
mutated in cancer samples.
We find evidence of both structural and numerical CIN. Loss of
centromeric cohesion is likely to disrupt accurate chromosome
segregation andwould therefore lead to numerical CIN. Although
it is less obvious how a defect in cohesion at the centromere
would lead to structural CIN, evidence of both structural and
numerical CIN has been reported for cells lacking other mem-
bers of the centromere-specific cohesion pathway, i.e., SA2
and PDS5B (Brough et al., 2012; Carretero et al., 2013; Kong
et al., 2014; Solomon et al., 2011). Cohesin is recruited to sites
of DNA damage in order to promote recombination-basedrepair, and in yeast this is dependent on RSC (Oum et al.,
2011). Interestingly, a recent report suggests that SA2, but not
SA1, is recruited to sites of DNA damage (Kong et al., 2014).
Together, these findings raise the intriguing possibility that the
establishment of cohesion in response to DNA damage is medi-
ated specifically by the centromere-specific cohesion pathway.
These results demonstrate a role for BAF180 in promoting
genome stability that is distinct from its well-characterized role
in transcriptional regulation. The discovery that BAF180 contrib-
utes to cohesion suggests potential directions for therapeutic in-
terventions for BAF180-deficient tumors.
EXPERIMENTAL PROCEDURES
Cell Culture Conditions, Strains, Plasmids, and Antibodies
For details regarding the cell culture conditions, strains, plasmids, and anti-
bodies used in this work, see Supplemental Experimental Procedures.
Metaphase Spreads
To arrest cells in metaphase, the cells were treated with 0.1 mg/ml colcemid for
3 hr, trypsinized, swollen in 75 mM KCl for 20 min at room temperature, and
fixed in Carnoy’s fixative (methanol/acetic acid 3:1). Cells were spotted onto
a slide floating in a 37C waterbath and dried overnight at room temperature.Cell Reports 6, 973–981, March 27, 2014 ª2014 The Authors 979
Table 1. Average Number and Range per Cell of Chromosomal
Aberrations in mESCs following MMC Exposure
Category +/+ /
Chromatid breaks 0.5 (0–3) 2.2 (0–14)
Chromosome breaks 0.3 (0–4) 0.8 (0–10)
Triradial 0.1 (0–2) 0.1 (0–1)
Quadriradial 0 (0–0) 0.02 (0–1)
Fusion 0.3 (0–2) 0.5 (0–8)
Total 2.2 (0–6) 4.6 (0–32)DNA staining was performed using ProLong Gold Antifade Reagent (Life Tech-
nologies) with DAPI. For the mESC cohesion assays, 200 spreads were
analyzed for each genotype. Centromeric cohesion was scored as ‘‘normal’’
when fewer than three chromosomes showed gaps between sister chromatid
centromeres, or ‘‘defective’’ whenmore than two chromosomes showed gaps.
Arm cohesion was scored as ‘‘normal’’ when fewer than three chromosomes
showed fully separated chromosome arms, or ‘‘defective’’ when more than
two chromosomes showed fully separated chromosome arms. For chromo-
some counts, 100 cells were analyzed for each cell type, with and without
treatment with 0.04 mg/ml MMC for 40 hr prior to metaphase arrest. The
same conditions were used for analysis of structural chromosome aberrations,
with 2,033 and 2,133 chromosomes analyzed for +/+ and / mESCs,
respectively.
FISH
1BR-hTERT cells transfected with siControl or siBAF180 were treated with
0.1 mg/ml colcemid for 3 hr to arrest inmetaphase beforemitotic cells were dis-
lodged. Cells were washed with PBS and fixed in Carnoy’s fixative. FISH was
performed essentially as described previously (Canudas and Smith, 2009).
Cells were hybridized overnight with either DNA probes against arm and
centromere regions of chromosome 10 (DiGeorge II probe, LPU015; Cytocell)
or subtelomeric regions of chromosome 16 (chromosome 16ptel05 probe,
LPT16R; Cytocell) according to the manufacturer’s protocol. Nuclei were
stained with ProLong Gold Antifade Reagent with DAPI.
Transcript Analysis
RNAwas extracted from the indicated cell lines using an RNeasy kit (QIAGEN).
Then 1 mg of RNA was reverse transcribed into cDNA for analysis by qPCR
using primers specific to the indicated locus (using QuantiTect Primer Mix
from QIAGEN).
IF-FISH
For IF-FISH, 4 3 105 U20S cells were plated onto glass coverslips and trans-
fected with 20 nM BAF180 single siRNA (Invitrogen) or nontargeting control
siRNA using HiPerFect transfection reagent (QIAGEN). After 19 hr, cells were
treated with 2.5 mM thymidine for 17 hr before being released. At 9 hr after
release, cells were transfected with the siRNA-resistant plasmids pEGFP,
pEGFP-BAF180r, pEGFP-BAF180r-T232P, and pEGFP-BAF180r-M538I using
NanoJuice Core transfection reagent (Merck Chemicals). After 5 hr, the cells
were washed with PBS and subjected to a second thymidine block using
2.5 mM thymidine for a further 17 hr. At 8 hr after release, the cells were fixed
with 3% paraformaldehyde (PFA).
For IF, cells were blocked in blocking solution (3% BSA, 0.1% Triton X-100,
1 mM EDTA pH 8.0 in PBS) for 30 min at room temperature, and subjected to
antibody incubation in blocking solution. Immunostained cells were fixed in
3% PFA for 10 min at room temperature. DNA FISH was performed according
to Chaumeil et al. (2008). Nuclei were stained with ProLong Gold Antifade
Reagent with DAPI.
Yeast Survival and Recombination Assays
Cultures ofDrsc2DMY3010 strain transformedwith pRsc2-myc, pRsc2-T67P-
myc, pRsc2-M280I-myc, pRsc2-H458P-myc, or pRsc2-D540G-myc plasmids
were grown to mid-log phase in synthetic complete media lacking tryptophan.980 Cell Reports 6, 973–981, March 27, 2014 ª2014 The AuthorsSerial dilutions were spotted or plated onto plates containing the indicated
drug. Colonies for survival assays were counted 3 days after plating. Recom-
bination assays were performed as described previously (Huang et al., 2006).
Ten- to twenty-thousand colonies were analyzed per strain.
Analysis of Micronuclei and Aberrant Mitoses
For mESCs, spontaneous micronuclei were counted in interphase cells from
two independent experiments (total counts: 983 +/+ cells, 1,043 / cells).
For 1BR-hTERT cells, three separate knockdown experiments were analyzed
(total counts: 2,629 for siControl, 2,716 for siBAF180). In experiments to
analyze the effect ofMMConmicronuclei formation, 563 +/+ and 676/ cells
were counted. DNA staining was performed using ProLong Gold Antifade
Reagent with DAPI. Analysis of aberrant mitoses was performed on 183 +/+
and 207 / anaphase mESCs from two independent experiments.
Viability Assays
Viability assays following treatment with MMC were performed in 96-well
format in triplicate at the stated doses; 1 3 104 mESCs and 5 3 103 1BR-
hTERT cells were plated per well. Viability was analyzed 4 days following treat-
ment using CellTiter-Glo Reagent (Promega).
Statistical Analyses
Frequency counts for cohesion scoring, spontaneous micronuclei, abnormal
anaphases, and structural chromosome aberration assays were analyzed
with a two-tailed Fisher’s exact test using GraphPad software. Distribution
counts from FISH experiments were analyzed using the Kolmogorov-Smirnov
test. Differences in recombination frequency and survival assays were
analyzed with an unpaired two-tailed t test using GraphPad software. Signifi-
cance was indicated as *p < 0.05, **p < 0.01, ***p < 0.001.
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